nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.281	1	CbGaD
Trifluoperazine—XDH—Cisplatin—peripheral nervous system neoplasm	0.106	0.279	CbGbCtD
Trifluoperazine—XDH—Doxorubicin—peripheral nervous system neoplasm	0.0709	0.187	CbGbCtD
Trifluoperazine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0346	0.0913	CbGbCtD
Trifluoperazine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0303	0.0799	CbGbCtD
Trifluoperazine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0303	0.0799	CbGbCtD
Trifluoperazine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0277	0.073	CbGbCtD
Trifluoperazine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.021	0.0554	CbGbCtD
Trifluoperazine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0135	0.0357	CbGbCtD
Trifluoperazine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0129	0.0341	CbGbCtD
Trifluoperazine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.012	0.0318	CbGbCtD
Trifluoperazine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0118	0.0312	CbGbCtD
Trifluoperazine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00808	0.0213	CbGbCtD
Trifluoperazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00677	0.0948	CbGeAlD
Trifluoperazine—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.00407	0.0569	CbGeAlD
Trifluoperazine—HTR6—ganglion—peripheral nervous system neoplasm	0.00308	0.0431	CbGeAlD
Trifluoperazine—CALY—trigeminal ganglion—peripheral nervous system neoplasm	0.00291	0.0407	CbGeAlD
Trifluoperazine—CALM1—cranial nerve—peripheral nervous system neoplasm	0.0029	0.0405	CbGeAlD
Trifluoperazine—CALM2—pons—peripheral nervous system neoplasm	0.00288	0.0402	CbGeAlD
Trifluoperazine—CALM1—pons—peripheral nervous system neoplasm	0.00286	0.0401	CbGeAlD
Trifluoperazine—S100A4—trigeminal ganglion—peripheral nervous system neoplasm	0.00251	0.0352	CbGeAlD
Trifluoperazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00248	0.0347	CbGeAlD
Trifluoperazine—S100A4—parotid gland—peripheral nervous system neoplasm	0.00237	0.0332	CbGeAlD
Trifluoperazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00232	0.0324	CbGeAlD
Trifluoperazine—TNNC1—trigeminal ganglion—peripheral nervous system neoplasm	0.00212	0.0296	CbGeAlD
Trifluoperazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00178	0.0249	CbGeAlD
Trifluoperazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00176	0.0247	CbGeAlD
Trifluoperazine—HTR2A—pons—peripheral nervous system neoplasm	0.00174	0.0244	CbGeAlD
Trifluoperazine—HTR1A—ganglion—peripheral nervous system neoplasm	0.0015	0.021	CbGeAlD
Trifluoperazine—CALM2—nerve—peripheral nervous system neoplasm	0.00149	0.0209	CbGeAlD
Trifluoperazine—CALM1—nerve—peripheral nervous system neoplasm	0.00148	0.0208	CbGeAlD
Trifluoperazine—CALM2—ganglion—peripheral nervous system neoplasm	0.00147	0.0206	CbGeAlD
Trifluoperazine—CALM1—ganglion—peripheral nervous system neoplasm	0.00147	0.0205	CbGeAlD
Trifluoperazine—S100A4—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00146	0.181	CbGdCrCtD
Trifluoperazine—S100A4—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.181	CbGdCrCtD
Trifluoperazine—S100A4—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00146	0.181	CbGdCrCtD
Trifluoperazine—S100A4—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.181	CbGdCrCtD
Trifluoperazine—EBPL—cerebellum—peripheral nervous system neoplasm	0.00139	0.0194	CbGeAlD
Trifluoperazine—DRD2—nerve—peripheral nervous system neoplasm	0.00137	0.0192	CbGeAlD
Trifluoperazine—DRD2—ganglion—peripheral nervous system neoplasm	0.00135	0.019	CbGeAlD
Trifluoperazine—CALY—cerebellum—peripheral nervous system neoplasm	0.00127	0.0178	CbGeAlD
Trifluoperazine—S100A4—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.137	CbGdCrCtD
Trifluoperazine—S100A4—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.137	CbGdCrCtD
Trifluoperazine—S100A4—cerebellum—peripheral nervous system neoplasm	0.0011	0.0153	CbGeAlD
Trifluoperazine—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.000921	0.0129	CbGeAlD
Trifluoperazine—HTR2A—nerve—peripheral nervous system neoplasm	0.000904	0.0127	CbGeAlD
Trifluoperazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.000893	0.0125	CbGeAlD
Trifluoperazine—CALM3—parotid gland—peripheral nervous system neoplasm	0.000869	0.0122	CbGeAlD
Trifluoperazine—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000823	0.0115	CbGeAlD
Trifluoperazine—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.000777	0.0109	CbGeAlD
Trifluoperazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000774	0.0108	CbGeAlD
Trifluoperazine—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000724	0.0101	CbGeAlD
Trifluoperazine—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.00072	0.0101	CbGeAlD
Trifluoperazine—CALM2—parotid gland—peripheral nervous system neoplasm	0.000682	0.00955	CbGeAlD
Trifluoperazine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000651	0.00912	CbGeAlD
Trifluoperazine—CALM2—brainstem—peripheral nervous system neoplasm	0.00064	0.00896	CbGeAlD
Trifluoperazine—CALM1—brainstem—peripheral nervous system neoplasm	0.000637	0.00892	CbGeAlD
Trifluoperazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.000602	0.202	CrCbGaD
Trifluoperazine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000601	0.0084	CbGeAlD
Trifluoperazine—DRD2—brainstem—peripheral nervous system neoplasm	0.000589	0.00824	CbGeAlD
Trifluoperazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000525	0.00735	CbGeAlD
Trifluoperazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000493	0.166	CrCbGaD
Trifluoperazine—CALM3—cerebellum—peripheral nervous system neoplasm	0.000402	0.00563	CbGeAlD
Trifluoperazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000388	0.00543	CbGeAlD
Trifluoperazine—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.000359	0.00503	CbGeAlD
Trifluoperazine—Flupentixol—ABCB1—peripheral nervous system neoplasm	0.000355	0.119	CrCbGaD
Trifluoperazine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00198	CcSEcCtD
Trifluoperazine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000326	0.00197	CcSEcCtD
Trifluoperazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000325	0.00197	CcSEcCtD
Trifluoperazine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000323	0.00196	CcSEcCtD
Trifluoperazine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000323	0.00196	CcSEcCtD
Trifluoperazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000322	0.00195	CcSEcCtD
Trifluoperazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000322	0.00195	CcSEcCtD
Trifluoperazine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000321	0.00449	CbGeAlD
Trifluoperazine—Gait disturbance—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00194	CcSEcCtD
Trifluoperazine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000319	0.00193	CcSEcCtD
Trifluoperazine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000318	0.00193	CcSEcCtD
Trifluoperazine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00192	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00192	CcSEcCtD
Trifluoperazine—CALM2—cerebellum—peripheral nervous system neoplasm	0.000316	0.00442	CbGeAlD
Trifluoperazine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00191	CcSEcCtD
Trifluoperazine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.00191	CcSEcCtD
Trifluoperazine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000315	0.00191	CcSEcCtD
Trifluoperazine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000315	0.00191	CcSEcCtD
Trifluoperazine—CALM1—cerebellum—peripheral nervous system neoplasm	0.000314	0.0044	CbGeAlD
Trifluoperazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000314	0.0019	CcSEcCtD
Trifluoperazine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000313	0.00189	CcSEcCtD
Trifluoperazine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000313	0.00189	CcSEcCtD
Trifluoperazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000313	0.00189	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.00189	CcSEcCtD
Trifluoperazine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000311	0.00189	CcSEcCtD
Trifluoperazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00031	0.00188	CcSEcCtD
Trifluoperazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00031	0.00188	CcSEcCtD
Trifluoperazine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00188	CcSEcCtD
Trifluoperazine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000309	0.00187	CcSEcCtD
Trifluoperazine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000298	0.00181	CcSEcCtD
Trifluoperazine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000296	0.00414	CbGeAlD
Trifluoperazine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.00178	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00177	CcSEcCtD
Trifluoperazine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00177	CcSEcCtD
Trifluoperazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00029	0.00176	CcSEcCtD
Trifluoperazine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00029	0.00176	CcSEcCtD
Trifluoperazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.00029	0.00406	CbGeAlD
Trifluoperazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000289	0.00175	CcSEcCtD
Trifluoperazine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000288	0.00175	CcSEcCtD
Trifluoperazine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000288	0.00175	CcSEcCtD
Trifluoperazine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000288	0.00402	CbGeAlD
Trifluoperazine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00174	CcSEcCtD
Trifluoperazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000287	0.00174	CcSEcCtD
Trifluoperazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000287	0.00174	CcSEcCtD
Trifluoperazine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000284	0.00172	CcSEcCtD
Trifluoperazine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.00171	CcSEcCtD
Trifluoperazine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000281	0.0017	CcSEcCtD
Trifluoperazine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.0017	CcSEcCtD
Trifluoperazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00169	CcSEcCtD
Trifluoperazine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000276	0.00167	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00167	CcSEcCtD
Trifluoperazine—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00165	CcSEcCtD
Trifluoperazine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00027	0.00164	CcSEcCtD
Trifluoperazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000269	0.00163	CcSEcCtD
Trifluoperazine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00163	CcSEcCtD
Trifluoperazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000267	0.00162	CcSEcCtD
Trifluoperazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000267	0.00162	CcSEcCtD
Trifluoperazine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00162	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000265	0.0016	CcSEcCtD
Trifluoperazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000264	0.0016	CcSEcCtD
Trifluoperazine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000262	0.00159	CcSEcCtD
Trifluoperazine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00159	CcSEcCtD
Trifluoperazine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00158	CcSEcCtD
Trifluoperazine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00026	0.00158	CcSEcCtD
Trifluoperazine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.00158	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000259	0.00157	CcSEcCtD
Trifluoperazine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000259	0.00157	CcSEcCtD
Trifluoperazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00156	CcSEcCtD
Trifluoperazine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.00156	CcSEcCtD
Trifluoperazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00156	CcSEcCtD
Trifluoperazine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000257	0.00156	CcSEcCtD
Trifluoperazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00156	CcSEcCtD
Trifluoperazine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.00155	CcSEcCtD
Trifluoperazine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000257	0.00155	CcSEcCtD
Trifluoperazine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000256	0.00155	CcSEcCtD
Trifluoperazine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000253	0.00153	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00153	CcSEcCtD
Trifluoperazine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000253	0.00153	CcSEcCtD
Trifluoperazine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000252	0.00153	CcSEcCtD
Trifluoperazine—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00153	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00152	CcSEcCtD
Trifluoperazine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00151	CcSEcCtD
Trifluoperazine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.00151	CcSEcCtD
Trifluoperazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000247	0.0015	CcSEcCtD
Trifluoperazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00148	CcSEcCtD
Trifluoperazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00148	CcSEcCtD
Trifluoperazine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000242	0.00146	CcSEcCtD
Trifluoperazine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00146	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00145	CcSEcCtD
Trifluoperazine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00024	0.00145	CcSEcCtD
Trifluoperazine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00024	0.00145	CcSEcCtD
Trifluoperazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00024	0.00145	CcSEcCtD
Trifluoperazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00145	CcSEcCtD
Trifluoperazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000238	0.0799	CrCbGaD
Trifluoperazine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00144	CcSEcCtD
Trifluoperazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000235	0.00143	CcSEcCtD
Trifluoperazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00142	CcSEcCtD
Trifluoperazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000234	0.00142	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000234	0.00142	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00142	CcSEcCtD
Trifluoperazine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00141	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00141	CcSEcCtD
Trifluoperazine—Rash—Topotecan—peripheral nervous system neoplasm	0.00023	0.0014	CcSEcCtD
Trifluoperazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00023	0.0014	CcSEcCtD
Trifluoperazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00023	0.00139	CcSEcCtD
Trifluoperazine—Cough—Etoposide—peripheral nervous system neoplasm	0.000229	0.00139	CcSEcCtD
Trifluoperazine—Headache—Topotecan—peripheral nervous system neoplasm	0.000229	0.00139	CcSEcCtD
Trifluoperazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.00139	CcSEcCtD
Trifluoperazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000229	0.00139	CcSEcCtD
Trifluoperazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000228	0.00138	CcSEcCtD
Trifluoperazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000228	0.00138	CcSEcCtD
Trifluoperazine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000228	0.00138	CcSEcCtD
Trifluoperazine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000228	0.00138	CcSEcCtD
Trifluoperazine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Trifluoperazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Trifluoperazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Trifluoperazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000226	0.00137	CcSEcCtD
Trifluoperazine—Rash—Melphalan—peripheral nervous system neoplasm	0.000226	0.00137	CcSEcCtD
Trifluoperazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000225	0.00137	CcSEcCtD
Trifluoperazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000223	0.00135	CcSEcCtD
Trifluoperazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00133	CcSEcCtD
Trifluoperazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000218	0.00132	CcSEcCtD
Trifluoperazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00132	CcSEcCtD
Trifluoperazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00132	CcSEcCtD
Trifluoperazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000217	0.00132	CcSEcCtD
Trifluoperazine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00131	CcSEcCtD
Trifluoperazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000215	0.00131	CcSEcCtD
Trifluoperazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000215	0.00131	CcSEcCtD
Trifluoperazine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.0013	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000215	0.0013	CcSEcCtD
Trifluoperazine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00129	CcSEcCtD
Trifluoperazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000213	0.00129	CcSEcCtD
Trifluoperazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00128	CcSEcCtD
Trifluoperazine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00128	CcSEcCtD
Trifluoperazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00127	CcSEcCtD
Trifluoperazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000209	0.00127	CcSEcCtD
Trifluoperazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00127	CcSEcCtD
Trifluoperazine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000208	0.00126	CcSEcCtD
Trifluoperazine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000204	0.00124	CcSEcCtD
Trifluoperazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000204	0.00123	CcSEcCtD
Trifluoperazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Trifluoperazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00122	CcSEcCtD
Trifluoperazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.0002	0.00121	CcSEcCtD
Trifluoperazine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00121	CcSEcCtD
Trifluoperazine—Nefazodone—ABCB1—peripheral nervous system neoplasm	0.000198	0.0666	CrCbGaD
Trifluoperazine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.00119	CcSEcCtD
Trifluoperazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00119	CcSEcCtD
Trifluoperazine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00119	CcSEcCtD
Trifluoperazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000195	0.00118	CcSEcCtD
Trifluoperazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.00118	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00117	CcSEcCtD
Trifluoperazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000193	0.0649	CrCbGaD
Trifluoperazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00117	CcSEcCtD
Trifluoperazine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000192	0.00117	CcSEcCtD
Trifluoperazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000191	0.00268	CbGeAlD
Trifluoperazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000191	0.00116	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00116	CcSEcCtD
Trifluoperazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000191	0.00116	CcSEcCtD
Trifluoperazine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00019	0.00115	CcSEcCtD
Trifluoperazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00114	CcSEcCtD
Trifluoperazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.00113	CcSEcCtD
Trifluoperazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000186	0.00113	CcSEcCtD
Trifluoperazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00113	CcSEcCtD
Trifluoperazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000185	0.00112	CcSEcCtD
Trifluoperazine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000185	0.00112	CcSEcCtD
Trifluoperazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00111	CcSEcCtD
Trifluoperazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000183	0.00111	CcSEcCtD
Trifluoperazine—Trazodone—ABCB1—peripheral nervous system neoplasm	0.000183	0.0616	CrCbGaD
Trifluoperazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.0011	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00108	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.00108	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00107	CcSEcCtD
Trifluoperazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.00107	CcSEcCtD
Trifluoperazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00107	CcSEcCtD
Trifluoperazine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000175	0.00106	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00106	CcSEcCtD
Trifluoperazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00105	CcSEcCtD
Trifluoperazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00105	CcSEcCtD
Trifluoperazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00105	CcSEcCtD
Trifluoperazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00104	CcSEcCtD
Trifluoperazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00017	0.00103	CcSEcCtD
Trifluoperazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00103	CcSEcCtD
Trifluoperazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00017	0.00103	CcSEcCtD
Trifluoperazine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000168	0.00102	CcSEcCtD
Trifluoperazine—Rash—Vincristine—peripheral nervous system neoplasm	0.000167	0.00101	CcSEcCtD
Trifluoperazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000167	0.00101	CcSEcCtD
Trifluoperazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00101	CcSEcCtD
Trifluoperazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000166	0.00101	CcSEcCtD
Trifluoperazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000989	CcSEcCtD
Trifluoperazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000987	CcSEcCtD
Trifluoperazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000158	0.000958	CcSEcCtD
Trifluoperazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000157	0.000953	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000935	CcSEcCtD
Trifluoperazine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000154	0.000933	CcSEcCtD
Trifluoperazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000152	0.00092	CcSEcCtD
Trifluoperazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000149	0.0499	CrCbGaD
Trifluoperazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000895	CcSEcCtD
Trifluoperazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000894	CcSEcCtD
Trifluoperazine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000893	CcSEcCtD
Trifluoperazine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000867	CcSEcCtD
Trifluoperazine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000142	0.00086	CcSEcCtD
Trifluoperazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000858	CcSEcCtD
Trifluoperazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000843	CcSEcCtD
Trifluoperazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000841	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000826	CcSEcCtD
Trifluoperazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000136	0.0457	CrCbGaD
Trifluoperazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00082	CcSEcCtD
Trifluoperazine—Rash—Etoposide—peripheral nervous system neoplasm	0.000135	0.00082	CcSEcCtD
Trifluoperazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000135	0.000819	CcSEcCtD
Trifluoperazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000134	0.000814	CcSEcCtD
Trifluoperazine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000802	CcSEcCtD
Trifluoperazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000799	CcSEcCtD
Trifluoperazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000794	CcSEcCtD
Trifluoperazine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000779	CcSEcCtD
Trifluoperazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000779	CcSEcCtD
Trifluoperazine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000774	CcSEcCtD
Trifluoperazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000127	0.000772	CcSEcCtD
Trifluoperazine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000125	0.00176	CbGeAlD
Trifluoperazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000759	CcSEcCtD
Trifluoperazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000743	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000739	CcSEcCtD
Trifluoperazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.00012	0.0405	CrCbGaD
Trifluoperazine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000729	CcSEcCtD
Trifluoperazine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000721	CcSEcCtD
Trifluoperazine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000716	CcSEcCtD
Trifluoperazine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000708	CcSEcCtD
Trifluoperazine—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000115	0.0387	CrCbGaD
Trifluoperazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000695	CcSEcCtD
Trifluoperazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000688	CcSEcCtD
Trifluoperazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000681	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000674	CcSEcCtD
Trifluoperazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000659	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000655	CcSEcCtD
Trifluoperazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00065	CcSEcCtD
Trifluoperazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000648	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000643	CcSEcCtD
Trifluoperazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000633	CcSEcCtD
Trifluoperazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00063	CcSEcCtD
Trifluoperazine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000628	CcSEcCtD
Trifluoperazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000623	CcSEcCtD
Trifluoperazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00061	CcSEcCtD
Trifluoperazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000601	CcSEcCtD
Trifluoperazine—Clozapine—ABCB1—peripheral nervous system neoplasm	9.91e-05	0.0333	CrCbGaD
Trifluoperazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000599	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000586	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000581	CcSEcCtD
Trifluoperazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000579	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000577	CcSEcCtD
Trifluoperazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000576	CcSEcCtD
Trifluoperazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	9.32e-05	0.0313	CrCbGaD
Trifluoperazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000537	CcSEcCtD
Trifluoperazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000536	CcSEcCtD
Trifluoperazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000533	CcSEcCtD
Trifluoperazine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000523	CcSEcCtD
Trifluoperazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000516	CcSEcCtD
Trifluoperazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000497	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000484	CcSEcCtD
Trifluoperazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000482	CcSEcCtD
Trifluoperazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000477	CcSEcCtD
Trifluoperazine—Rash—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000459	CcSEcCtD
Trifluoperazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000459	CcSEcCtD
Trifluoperazine—Headache—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000456	CcSEcCtD
Trifluoperazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000446	CcSEcCtD
Trifluoperazine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000433	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000425	CcSEcCtD
Trifluoperazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000425	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000422	CcSEcCtD
Trifluoperazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.0004	CcSEcCtD
Trifluoperazine—CALM2—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	1.45e-05	0.000157	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000157	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.43e-05	0.000155	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.43e-05	0.000155	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.43e-05	0.000154	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000152	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.41e-05	0.000152	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.4e-05	0.000152	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.39e-05	0.00015	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.39e-05	0.00015	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000149	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000149	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.35e-05	0.000146	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000143	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000142	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.3e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.3e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.29e-05	0.00014	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—NRAS—peripheral nervous system neoplasm	1.28e-05	0.000138	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—NRAS—peripheral nervous system neoplasm	1.28e-05	0.000138	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000137	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.27e-05	0.000137	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000137	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.26e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.26e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000134	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GNAS—peripheral nervous system neoplasm	1.24e-05	0.000134	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GNAS—peripheral nervous system neoplasm	1.24e-05	0.000134	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.23e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.000131	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.21e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.2e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.2e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.000129	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.19e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.19e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.19e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.19e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.17e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PTPN11—peripheral nervous system neoplasm	1.15e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.15e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.15e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.14e-05	0.000123	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.13e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.13e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PTPN11—peripheral nervous system neoplasm	1.11e-05	0.00012	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PTPN11—peripheral nervous system neoplasm	1.11e-05	0.00012	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.11e-05	0.00012	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000119	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000119	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000115	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.06e-05	0.000114	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.05e-05	0.000114	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.04e-05	0.000113	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.04e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.04e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.04e-05	0.000112	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.000111	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.02e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—peripheral nervous system neoplasm	1.01e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.01e-05	0.000109	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.01e-05	0.000109	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	9.95e-06	0.000108	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.95e-06	0.000108	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—peripheral nervous system neoplasm	9.78e-06	0.000106	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—peripheral nervous system neoplasm	9.78e-06	0.000106	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	9.71e-06	0.000105	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—HRAS—peripheral nervous system neoplasm	9.66e-06	0.000104	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.64e-06	0.000104	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	9.5e-06	0.000103	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—HRAS—peripheral nervous system neoplasm	9.35e-06	0.000101	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—HRAS—peripheral nervous system neoplasm	9.35e-06	0.000101	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.28e-06	0.0001	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.23e-06	9.97e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.13e-06	9.87e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.12e-06	9.85e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.11e-06	9.85e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ERBB2—peripheral nervous system neoplasm	9.11e-06	9.84e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.97e-06	9.7e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.97e-06	9.69e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.95e-06	9.68e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.94e-06	9.66e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.81e-06	9.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ERBB2—peripheral nervous system neoplasm	8.81e-06	9.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	8.81e-06	9.52e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.79e-06	9.49e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.7e-06	9.4e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	8.53e-06	9.22e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.44e-06	9.12e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.42e-06	9.1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.42e-06	9.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	8.41e-06	9.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	8.36e-06	9.03e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	8.26e-06	8.92e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	8.26e-06	8.92e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.21e-06	8.87e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.17e-06	8.83e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	8.13e-06	8.79e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	8.13e-06	8.79e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	8.08e-06	8.73e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	8.08e-06	8.73e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.86e-06	8.49e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	7.76e-06	8.38e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.73e-06	8.36e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.69e-06	8.31e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.68e-06	8.3e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.61e-06	8.22e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.58e-06	8.19e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.52e-06	8.13e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.48e-06	8.08e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.45e-06	8.05e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.45e-06	8.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.43e-06	8.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.43e-06	8.03e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.41e-06	8.01e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	7.38e-06	7.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.33e-06	7.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.33e-06	7.93e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.21e-06	7.79e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.21e-06	7.79e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.21e-06	7.79e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	7.14e-06	7.71e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	7.14e-06	7.71e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.09e-06	7.66e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.08e-06	7.65e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.96e-06	7.52e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.94e-06	7.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	6.93e-06	7.49e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.83e-06	7.38e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.79e-06	7.34e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.79e-06	7.34e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	6.7e-06	7.24e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	6.7e-06	7.24e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.68e-06	7.22e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.67e-06	7.2e-05	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.6e-06	7.14e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.56e-06	7.09e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.54e-06	7.07e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.54e-06	7.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.5e-06	7.02e-05	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.48e-06	7.01e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.45e-06	6.97e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.44e-06	6.96e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.42e-06	6.94e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NRAS—peripheral nervous system neoplasm	6.4e-06	6.91e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.38e-06	6.89e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.36e-06	6.87e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.32e-06	6.83e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.3e-06	6.81e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.25e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.21e-06	6.71e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NRAS—peripheral nervous system neoplasm	6.19e-06	6.69e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NRAS—peripheral nervous system neoplasm	6.19e-06	6.69e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.17e-06	6.67e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6e-06	6.48e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—peripheral nervous system neoplasm	5.96e-06	6.44e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.9e-06	6.38e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.89e-06	6.36e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.89e-06	6.36e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.82e-06	6.29e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.79e-06	6.26e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.79e-06	6.25e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.78e-06	6.24e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—peripheral nervous system neoplasm	5.76e-06	6.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—peripheral nervous system neoplasm	5.76e-06	6.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.69e-06	6.15e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.69e-06	6.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.55e-06	5.99e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.48e-06	5.93e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.45e-06	5.89e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.4e-06	5.83e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.38e-06	5.82e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.37e-06	5.8e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.37e-06	5.8e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.34e-06	5.77e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.3e-06	5.72e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.28e-06	5.71e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.17e-06	5.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.17e-06	5.59e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.11e-06	5.52e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	5.07e-06	5.48e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.03e-06	5.43e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.01e-06	5.42e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.93e-06	5.33e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.92e-06	5.32e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	4.9e-06	5.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	4.9e-06	5.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.9e-06	5.29e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.78e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.75e-06	5.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.74e-06	5.12e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.74e-06	5.12e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—peripheral nervous system neoplasm	4.68e-06	5.06e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.57e-06	4.94e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.55e-06	4.91e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—peripheral nervous system neoplasm	4.53e-06	4.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—peripheral nervous system neoplasm	4.53e-06	4.89e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.48e-06	4.84e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	4.47e-06	4.84e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.33e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.33e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	4.33e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	4.33e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.19e-06	4.53e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.17e-06	4.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—peripheral nervous system neoplasm	4.13e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.13e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.12e-06	4.45e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.05e-06	4.38e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.04e-06	4.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.04e-06	4.36e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.04e-06	4.36e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.03e-06	4.36e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.01e-06	4.34e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.01e-06	4.33e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—peripheral nervous system neoplasm	4e-06	4.32e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—peripheral nervous system neoplasm	4e-06	4.32e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.95e-06	4.27e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.94e-06	4.26e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.88e-06	4.19e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.86e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.54e-06	3.83e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.49e-06	3.77e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.48e-06	3.76e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.46e-06	3.74e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.43e-06	3.7e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.42e-06	3.7e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.41e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	3.35e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	3.35e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.31e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.31e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.28e-06	3.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.17e-06	3.43e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.17e-06	3.43e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.89e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.8e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.8e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.62e-06	2.83e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.09e-06	2.26e-05	CbGpPWpGaD
